Sarepta Therapeutics Inc (SRPT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.45
• Market Cap: $1.99B
• EPS: $-2.83
• 52-Week High: $108.48
• 52-Week Low: $10.41

Market Sentiment

Sarepta Therapeutics Inc currently has a Neutral sentiment score of -0.04.

About Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc. is a pioneering biopharmaceutical company based in Cambridge, Massachusetts, that focuses on the development of RNA-targeted and gene therapies for rare genetic disorders, particularly Duchenne muscular dystrophy (DMD). With an innovative pipeline and a strong commitment to addressing significant unmet medical needs, Sarepta is reshaping treatment paradigms in genetic medicine. The company's advanced scientific expertise and cutting-edge technologies position it as ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sarepta Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SRPT pay dividends?

Sarepta Therapeutics Inc (SRPT) does not currently pay a regular dividend.

What is SRPT's market cap?

Sarepta Therapeutics Inc (SRPT) has a market capitalization of $1.99B with a current stock price of $17.45.